MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouzzine, M.
Right arrow Articles by Magdalou, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouzzine, M.
Right arrow Articles by Magdalou, J.

Vol. 58, Issue 6, 1609-1615, December 2000

ACCELERATED COMMUNICATION
Importance of Histidine Residues for the Function of the Human Liver UDP-Glucuronosyltransferase UGT1A6: Evidence for the Catalytic Role of Histidine 370

Mohamed Ouzzine, Laurence Antonio, Brian Burchell, Patrick Netter, Sylvie Fournel-Gigleux, and Jacques Magdalou

Unité Mixte de Recherche 7561 Centre National de la Recherche Scientifique-Université Henri Poincaré Nancy 1, Vandoeuvre-lès-Nancy, France (M.O., L.A., P.N., S.F.-G, J.M.); and Department of Molecular and Cellular Pathology, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (B.B.)

The human UDP-glucuronosyltransferase isoform UGT1A6 catalyzes the nucleophilic attack of phenolic xenobiotics on glucuronic acid, leading to the formation of water-soluble glucuronides. Based on the irreversible inhibition of the enzyme activity by the histidyl-selective reagent diethyl pyrocarbonate (DEPC), histidine was suggested to play a key role in the glucuronidation reaction. Therefore, the role of four strictly conserved histidine residues (His38, His361, His370, and His485) in the glucuronidation of 4-methylumbelliferone, as reporter substrate, was examined using site-directed mutagenesis. For this purpose, stable heterologous expression of wild-type and mutant UGT1A6 was achieved in the yeast Pichia pastoris. Replacement of histidine residues by alanine or glutamine led to fully inactive H38A, H38Q, and H485A mutants. Substitution of His361 by alanine affected the interaction of the enzyme with the cosubstrate, as indicated by a 4-fold increase in the Km value toward UDP-glucuronic acid. Interestingly, H370A mutant presented a severely impaired catalytic efficiency (with a Vmax value approximately 5% that of the wild-type), whereas conservative substitution of His370 by glutamine (H370Q) led to a significant restoration of activity. Whereas H361A was inactivated by DEPC as the wild-type enzyme, this chemical reagent only produced a minor effect on either H370Q or H370A mutant, providing evidence that His370 is probably the reactive histidine residue targeted by DEPC. The dramatic changes in catalytic efficiency on substitution of His370 by alanine and the ability of glutamine to function in place of histidine along with a weak sensitivity of these mutants to DEPC strongly suggest that His370 plays a catalytic role in the glucuronidation reaction.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Kakizaki, K. Kojima, K. Takagaki, M. Endo, R. Kannagi, M. Ito, Y. Maruo, H. Sato, T. Yasuda, S. Mita, et al.
A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone
J. Biol. Chem., August 6, 2004; 279(32): 33281 - 33289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gulberti, S. Fournel-Gigleux, G. Mulliert, A. Aubry, P. Netter, J. Magdalou, and M. Ouzzine
The Functional Glycosyltransferase Signature Sequence of the Human {beta}1,3-Glucuronosyltransferase Is a XDD Motif
J. Biol. Chem., August 22, 2003; 278(34): 32219 - 32226.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Antonio, J.-P. Grillasca, J. Taskinen, E. Elovaara, B. Burchell, M.-H. Piet, B. Ethell, M. Ouzzine, S. Fournel-Gigleux, and J. Magdalou
Characterization of Catechol Glucuronidation in Rat Liver
Drug Metab. Dispos., February 1, 2002; 30(2): 199 - 207.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics